Darryle D. Schoepp

16.9k citations

158 papers · 13.9k indexed · 5 hit papers · h-index 58

Impact in

Cellular and Molecular Neuroscience top 0.05%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Photoreceptor and optogenetics research
Biological Psychiatry top 0.2%
- Tryptophan and brain disorders

Papers in

Cellular and Molecular Neuroscience 137
- Neuroscience and Neuropharmacology Research 131
- Neurotransmitter Receptor Influence on Behavior 18
- Photoreceptor and optogenetics research 12
Biological Psychiatry 6

Co-authors: James A. Monn Bryan G. Johnson Jayne Cartmell P. Jeffrey Conn Rebecca A. Wright David E. Jane Craig R. Salhoff Joseph P. Tizzano
Journals: Neuropharmacology (21 papers)Journal of Medicinal Chemistry (18 papers)Journal of Neurochemistry (18 papers)Journal of Pharmacology and Experimental Therapeutics (11 papers)Bioorganic & Medicinal Chemistry Letters (7 papers)
Partner nations: United States United Kingdom Finland

In The Last Decade

Darryle D. Schoepp

156 papers receiving 13.6k citations

Hit Papers

5 papers align trajectories log scale

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial 2007 · 790 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Nature Medicine
2005 Neuron
2000 Journal of Neurochemistry
1999 Neuropharmacology
1993 Trends in Pharmacological Sciences

Peers

Countries citing papers authored by Darryle D. Schoepp

Since Specialization

Citations

This map shows the geographic impact of Darryle D. Schoepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darryle D. Schoepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darryle D. Schoepp more than expected).

Fields of papers citing papers by Darryle D. Schoepp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darryle D. Schoepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darryle D. Schoepp. The network helps show where Darryle D. Schoepp may publish in the future.

Co-authors

The 25 scholars most cited alongside Darryle D. Schoepp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Darryle D. Schoepp Line = papers co-authored together Darryle D. Schoepp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	mGlu2/3 receptor agonist (LY354740) in anxiety Pharmacology Biochemistry and Behavior ·Darryle D. Schoepp	2024	3
2	Alzheimer's disease research and development: a call for a new research roadmap Annals of the New York Academy of Sciences ·Howard Feldman, Magali Haas, Sam Gandy, Darryle D. Schoepp, A.J. Cross, Richard Mayeux, Reisa A. Sperling, Howard Fillit, Diana L. van de Hoef, Sonya Dougal, Jeffrey S. Nye	2014	30
3	5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: Interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740 Neuroscience Letters ·Gerard J. Marek, Rebecca A. Wright, Darryle D. Schoepp	2006	16
4	Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo Neuron ·John R. Cirrito, Kelvin A. Yamada, Mary Beth Finn, Robert S. Sloviter, Kelly R. Bales, Patrick C. May, Darryle D. Schoepp, Steven M. Paul, Steven Mennerick, David M. Holtzman Hit paper breakdown →	2005	1003
5	LY354740, an mGlu2/3 Receptor Agonist as a Novel Approach to Treat Anxiety/Stress Stress ·Darryle D. Schoepp, Rebecca A. Wright, Louise R. Levine, Brenda Gaydos, William Z. Potter	2003	175
6	Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum Brain Research ·Jayne Cartmell, Craig R. Salhoff, Kenneth W. Perry, James A. Monn, Darryle D. Schoepp	2000	40
7	LY3 54740: A Systemically Active mGlu2/mGlu3 Receptor Agonist CNS Drug Reviews ·Darryle D. Schoepp, James A. Monn, Gerard J. Marek, George A Ghajanian, Bita Moghaddam	1999	20
8	Neuroprotective Actions of Novel and Potent Ligands of Group I and Group II Metabotropic Glutamate Receptors Annals of the New York Academy of Sciences ·Anne Kingston, Michael J. O’Neill, A. Bond, Valeria Bruno, Giuseppe Battaglia, Ferdinando Nicoletti, John E. Harris, Barry P. Clark, James A. Monn, David Lodge, Darryle D. Schoepp	1999	47
9	[3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells Neuropharmacology ·Bryan G. Johnson, Rebecca A. Wright, M. Brian Arnold, William J. Wheeler, Paul L. Ornstein, Darryle D. Schoepp	1999	80
10	Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist Naunyn-Schmiedeberg s Archives of Pharmacology ·Darryle D. Schoepp, Bryan G. Johnson, Rebecca A. Wright, Craig R. Salhoff, James A. Monn	1998	19
11	Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid. Molecular Pharmacology ·R Bleakman, Darryle D. Schoepp, Barbara A. Ballyk, HYWEL R BUFTON, E F Sharpe, Kenneth A. Thomas, Paul L. Ornstein, R. K. Kamboj	1996	91
12	Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate Neuropharmacology ·Darryle D. Schoepp, Bryan G. Johnson, Craig R. Salhoff, M.J. Valu, Manisha Desai, J. Paul Burnett, Nancy G. Mayne, James A. Monn	1995	65
13	1-BCP, a memory-enhancing agent, selectively potentiates AMPA-induced [3H]norepinephrine release in rat hippocampal slices Neuropharmacology ·Manisha Desai, Matthew J. Valli, James A. Monn, Darryle D. Schoepp	1995	22
14	Molecular Cloning, Expression, and Pharmacological Characterization of humEAA1, a Human Kainate Receptor Subunit Journal of Neurochemistry ·Rajender K. Kamboj, Darryle D. Schoepp, Stephen L. Nutt, Lee R. Shekter, Bożena Korczak, Rebecca A. True, Vikarna Rampersad, Dennis M. Zimmerman, Michael A. Wosnick	1994	48
15	Striatal quinolinic acid lesions increase [3H]WIN 35,428 binding to the dopamine transporter Neurochemistry International ·Donald R. Gehlert, Darryle D. Schoepp	1992	6
16	Neuroprotectant effects of LY 274614, a structurally novel systemically active competitive NMDA receptor antagonist Journal of Neural Transmission ·Darryle D. Schoepp, Paul L. Ornstein, Craig R. Salhoff, J. David Leander	1991	37
17	Comparison of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD)- and 1R,3S-ACPD-stimulated brain phosphoinositide hydrolysis European Journal of Pharmacology Molecular Pharmacology ·Darryle D. Schoepp, Bryan G. Johnson, Rebecca A. True, James A. Monn	1991	76
18	D,L-(Tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist European Journal of Pharmacology ·Darryle D. Schoepp, C. Smith, David Lodge, John D. Millar, J. David Leander, Aida Sacaan, W. H. W. LUNN	1991	57
19	CGS-19755 and MK-801 selectively prevent rat striatal cholinergic and gabaergic neuronal degeneration induced by N-methyl-D-aspartate and ibotenate in vivo Journal of Neural Transmission ·Darryle D. Schoepp, Craig R. Salhoff, Charles C. Hillman, Paul L. Ornstein	1989	18
20	Estrogen modulation of angiotensin-stimulated phosphoinositide hydrolysis in slices of rat anterior pituitary Neurochemistry International ·Darryle D. Schoepp, Dianne A. Bailly	1987	8

About Darryle D. Schoepp

Darryle D. Schoepp is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry, Molecular Biology, Cognitive Neuroscience and Developmental Neuroscience, having authored 158 papers that have together received 13.9k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (131 papers), Receptor Mechanisms and Signaling (61 papers), Ion channel regulation and function (29 papers), Memory and Neural Mechanisms (21 papers), Neurotransmitter Receptor Influence on Behavior (18 papers), Chemical Synthesis and Analysis (13 papers), Photoreceptor and optogenetics research (12 papers) and Molecular Sensors and Ion Detection (10 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (11.2k citations), Biological Psychiatry (898 citations), Cognitive Neuroscience (2.7k citations), Neurology (949 citations) and Behavioral Neuroscience (408 citations). Darryle D. Schoepp has collaborated with scholars based in United States, United Kingdom and Finland. Frequent co-authors include James A. Monn, Bryan G. Johnson, Jayne Cartmell, P. Jeffrey Conn, Rebecca A. Wright, David E. Jane, Craig R. Salhoff, Joseph P. Tizzano, Paul L. Ornstein and Gerard J. Marek. Their work appears in journals such as Neuropharmacology, Journal of Medicinal Chemistry, Journal of Neurochemistry, Journal of Pharmacology and Experimental Therapeutics and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact